The clinical cure rate was significantly lower in the amoxicillin-clavulanate group than in the ciprofloxacin group (58% vs. 77%), regardless of whether the pathogens were susceptible or resistant ...

Brigham researchers found that patients prescribed amoxicillin-clavulanate had higher rates of gastrointestinal symptoms and yeast infections than those prescribed amoxicillin. Acute sinusitis is ...

This combination medication contains semisynthetic antibiotic amoxicillin and β-lactamase inhibitor, prescribed for lower respiratory infections, otitis media, sinusitis, urinary tract infections ...

The powder is typically mixed with water to form the liquid version of the drug, though other foods, like chocolate syrup or sugar ... recommends using amoxicillin clavulanate, intramuscular ...

The drugs amoxicillin and amoxicillin-clavulanate make up most of those prescriptions, but there is a lack of consensus on which should be first-line for children. ‘Acute sinusitis patients ...

Treatment failure with amoxicillin-clavulanate for pediatric acute sinusitis was similar compared with amoxicillin alone, but the broad-spectrum antibiotic may be associated with more adverse ...

Among three drugmakers, 29 amoxicillin and clavulanate oral presentations are on allocation or back order, according to the American Society of Health-System Pharmacists. The amoxicillin and ...

and Augmentin contains a combination of amoxicillin and clavulanate or clavulanic acid. This may make it more effective against some types of infections. Read more to learn about the differences ...

Treating outpatient diverticulitis with amoxicillin plus clavulanate may reduce the risk of fluoroquinolone-related harms with no adverse impact on diverticulitis-specific outcomes, two nationwide ...

The 1-year risk for C. difficile was higher for patients who received metronidazole plus a fluoroquinolone than those who received amoxicillin-clavulanate (RD = 0.6 percentage points; 95% CI ...

Citation: Amoxicillin-clavulanate safe and effective compared with metronidazole-with-fluoroquinolone for diverticulitis (2021, February 23) retrieved 1 June 2025 from https://medicalxpress.com ...

The REASSURE trial was conducted to support the approval of the product following a letter from the FDA requesting additional study data. Sulopenem etzadroxil/probenecid was found to be ...